6M
ANIK icon

6 Meridian’s Anika Therapeutics ANIK Stock Holding History

6 Meridian’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5,691
Closed -$215K – 274
2020
Q2 		$215K Sell
5,691
-9,460
-62% -$312K 0.02% 280
2020
Q1 		$438K Buy
+15,151
New +$613K 0.05% 302
2018
Q4 		– Sell
-12,073
Closed -$509K – 400
2018
Q3 		$509K Buy
12,073
+932
+8% +$36.8K 0.05% 258
2018
Q2 		$357K Buy
11,141
+15
+0.1% +$618 0.04% 370
2018
Q1 		$553K Buy
+11,126
New +$629K 0.06% 181

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

6 Meridian's ANIK Position: Q3 2020 in Review

6 Meridian sold out of Anika Therapeutics (ANIK) in Q3 2020, closing a stake of 5,691 shares — an estimated $215K sold.

6 Meridian first reported a position in ANIK in Q1 2018 and held it in 5 quarters. The position peaked at $553K in Q1 2018. 156 funds tracked by Wall St. Rank hold ANIK as of Q3 2020.

  • 6 Meridian reported no remaining Anika Therapeutics position as of Q3 2020 after selling out during the quarter.
  • 6 Meridian sold 5,691 Anika Therapeutics shares in Q3 2020, an estimated $215K.
  • 6 Meridian first reported a position in Anika Therapeutics in Q1 2018 and held it in 5 quarters.
  • 6 Meridian's Anika Therapeutics position peaked at $553K in Q1 2018.
  • 156 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2020.

Based on 6 Meridian's 13F filing for Q3 2020, filed 19 Oct 2020.